EC
PRVA icon

EntryPoint Capital’s Privia Health PRVA Stock Holding History

EntryPoint Capital’s Portfolio PRVA Stock Details PRVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-8,582
Closed -$203K – 885
2025
Q4 		$203K Buy
+8,582
New +$209K 0.08% 547
2025
Q3 		– Sell
-18,301
Closed -$421K – 838
2025
Q2 		$421K Sell
18,301
-705
-4% -$16.3K 0.21% 153
2025
Q1 		$427K Sell
19,006
-2,360
-11% -$54.8K 0.2% 160
2024
Q4 		$418K Buy
+21,366
New +$423K 0.18% 189
2024
Q3 		– Sell
-7,420
Closed -$129K – 1197
2024
Q2 		$129K Buy
+7,420
New +$131K 0.06% 666

Other funds holding PRVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DCP
Durable Capital Partners Bethesda, Maryland $10.3B AUM 29.04% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RF
Rubicon Founders Nashville, Tennessee $196M AUM 53.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
VBA
Van Berkom & Associates Montreal, Quebec, Canada $3.1B AUM 12.88% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

EntryPoint Capital's PRVA Position: Q1 2026 in Review

EntryPoint Capital sold out of Privia Health (PRVA) in Q1 2026, closing a stake of 8,582 shares — an estimated $203K sold.

EntryPoint Capital first reported a position in PRVA in Q2 2024 and held it in 5 quarters. The position peaked at $427K in Q1 2025. 293 funds tracked by Wall St. Rank hold PRVA as of Q1 2026.

  • EntryPoint Capital reported no remaining Privia Health position as of Q1 2026 after selling out during the quarter.
  • EntryPoint Capital sold 8,582 Privia Health shares in Q1 2026, an estimated $203K.
  • EntryPoint Capital first reported a position in Privia Health in Q2 2024 and held it in 5 quarters.
  • EntryPoint Capital's Privia Health position peaked at $427K in Q1 2025.
  • 293 funds tracked by Wall St. Rank held Privia Health as of Q1 2026.

Based on EntryPoint Capital's 13F filing for Q1 2026, filed 14 May 2026.